Reaction from the US to the Baku-Iravan agreement
24 April 23:52
Home page Health |
A drug that halves a woman's risk of breast cancer continues to work long after they stop taking it, say researchers.
Axar.az reports citing BBC.
Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers.
It is already available on the NHS, but researchers at Queen Mary University of London said only a tenth of eligible women were receiving it.
Cancer Research UK said the findings were reassuring.
Date
2019.12.12 / 22:14
|
Author
Axar.az
|